ストックスクリーナーアプリを入手
11.54
11.82%
1.22
アフターアワーズ：
11.54
前日終値:
$10.32
開ける：
$11.01
24時間の取引高:
57,495
Relative Volume:
0.99
時価総額：
$68.79M
収益：
$100.44M
当期純損益:
$-133.16M
株価収益率:
-0.448
EPS:
-25.76
ネットキャッシュフロー:
$-94.85M
1週間 パフォーマンス:
+2.85%
1か月 パフォーマンス:
+25.03%
6か月 パフォーマンス:
+34.19%
1年 パフォーマンス:
+48.52%
1日の値動き範囲:
$10.87
$12.31
1週間の範囲:
$10.32
$12.31
52週間の値動き範囲:
$5.005
$18.70
Atara Biotherapeutics Inc Stock (ATRA) Company Profile
名前
Atara Biotherapeutics Inc
セクター
電話
805-623-4211
住所
1280 RANCHO CONEJO BLVD, THOUSAND OAKS, CA
ATRA を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
ATRA
Atara Biotherapeutics Inc
|
11.54 | 65.31M | 100.44M | -133.16M | -94.85M | -25.76 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 93.98B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 59.67B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 40.50B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.26B | 3.81B | -644.79M | -669.77M | -6.24 |
Atara Biotherapeutics Inc Stock (ATRA) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-11-09 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-11-09 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2023-11-09 | ダウングレード | Mizuho | Buy → Neutral |
| 2022-07-20 | ダウングレード | Citigroup | Neutral → Sell |
| 2022-07-13 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2022-07-13 | ダウングレード | Stifel | Buy → Hold |
| 2022-05-10 | ダウングレード | Citigroup | Buy → Neutral |
| 2021-05-13 | アップグレード | JP Morgan | Neutral → Overweight |
| 2020-12-09 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-08 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-11-10 | 繰り返されました | H.C. Wainwright | Buy |
| 2020-06-30 | 開始されました | Evercore ISI | Outperform |
| 2020-06-15 | 開始されました | H.C. Wainwright | Buy |
| 2020-04-23 | アップグレード | Citigroup | Neutral → Buy |
| 2019-11-08 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2019-09-27 | ダウングレード | Goldman | Neutral → Sell |
| 2019-09-16 | ダウングレード | Jefferies | Buy → Hold |
| 2019-06-04 | アップグレード | Citigroup | Sell → Neutral |
| 2019-05-30 | 開始されました | ROTH Capital | Buy |
| 2019-05-23 | 開始されました | Stifel | Buy |
| 2019-01-23 | 開始されました | Mizuho | Buy |
| 2018-04-10 | 開始されました | JP Morgan | Overweight |
| 2018-03-16 | 開始されました | Guggenheim | Neutral |
| 2018-03-05 | 繰り返されました | Jefferies | Buy |
| 2018-02-28 | ダウングレード | JMP Securities | Mkt Outperform → Mkt Perform |
| 2018-02-15 | ダウングレード | Citigroup | Neutral → Sell |
| 2018-01-03 | アップグレード | Citigroup | Sell → Neutral |
| 2017-10-06 | 再開されました | Goldman | Neutral |
すべてを表示
Atara Biotherapeutics Inc (ATRA) 最新ニュース
Is Atara Biotherapeutics Inc. building a consolidation baseDaily Investment Ideas with Market Insight - Newser
Technical signs of recovery in Atara Biotherapeutics Inc.Trend Confirmation Scanner with Entry Focus - Newser
How Atara Biotherapeutics Inc. stock performs during market volatilityConsistent Gain Plan with AI Support - Newser
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress - BioSpace
Atara Biotherapeutics shares rise 2.13% after-hours after FDA accepted BLA for tabelecleucel. - AInvest
Atara Biotherapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Atara Biotherapeutics Announces Second Quarter Financial Results and Operational Progress | ATRA Stock News - GuruFocus
Atara Biotherapeutics Reports Q2 Financial Results, Resumes Strategic Options Evaluation - AInvest
Will Atara Biotherapeutics Inc. price bounce be sustainableCapital Safe Picks with Consistent Gains - Newser
Understanding Atara Biotherapeutics Inc.’s price movementAI Powered Buy Point Forecast Planner - Newser
How to interpret RSI for Atara Biotherapeutics Inc. stockLow Drawdown Picks with Weekly Updates - Newser
What MACD signals say about Atara Biotherapeutics Inc.High Return Idea With Technical Filter - Newser
How high can Atara Biotherapeutics Inc. stock goFree Alert Feed for Momentum Based Picks - Newser
Is Atara Biotherapeutics Inc. showing signs of accumulationBuy Strategy Tracker with Growth Indicators - Newser
Multi asset correlation models including Atara Biotherapeutics Inc.Free Real Time Stock Movement Analysis - Newser
Risk vs reward if holding onto Atara Biotherapeutics Inc.Daily Profit Watch With Forecast Confidence - Newser
Atara ATRA Q2 2025 Earnings Preview Upside Potential on Strategic Partnerships - AInvest
Risk adjusted return profile for Atara Biotherapeutics Inc. analyzedMarket Liquidity and Price Flow Analysis - Newser
Atara Biotherapeutics Inc expected to post a loss of 46 cents a shareEarnings Preview - TradingView
Biotech with Heart: Atara’s Path to Hope for MS & Cancer - Tomorrow's World Today
Atara Biotherapeutics, Inc. (NASDAQ:ATRA) Is About To Turn The Corner - sg.finance.yahoo.com
What is Atara Biotherapeutics Inc. company’s growth strategyUnlock powerful portfolio management tools - Jammu Links News
What is the risk reward ratio of investing in Atara Biotherapeutics Inc. stockUnlock exclusive trading strategies for gains - Jammu Links News
What are analysts’ price targets for Atara Biotherapeutics Inc. in the next 12 monthsStrong return on investment - Jammu Links News
What are the latest earnings results for Atara Biotherapeutics Inc.Rapid wealth multiplication - Jammu Links News
Does Atara Biotherapeutics Inc. stock perform well during market downturnsHigh-yield trading alerts - Jammu Links News
When is Atara Biotherapeutics Inc. stock expected to show significant growthUnlock powerful portfolio optimization tools - Jammu Links News
What analysts say about Atara Biotherapeutics Inc. stockDiscover stocks with explosive upside potential - Jammu Links News
Should I hold or sell Atara Biotherapeutics Inc. stock in 2025Maximize profits with strategic stock selection - Jammu Links News
What institutional investors are buying Atara Biotherapeutics Inc. stockTriple-digit wealth increases - Jammu Links News
What are Atara Biotherapeutics Inc. company’s key revenue driversGet real-time alerts on top-performing stocks - Jammu Links News
What drives Atara Biotherapeutics Inc. stock priceUnlock daily market insights for better trades - Jammu Links News
What is the dividend policy of Atara Biotherapeutics Inc. stockMaximize returns with disciplined trading approaches - Jammu Links News
What catalysts could drive Atara Biotherapeutics Inc. stock higher in 2025Discover high-growth stocks for your portfolio - Jammu Links News
Why is Atara Biotherapeutics Inc. stock attracting strong analyst attentionInvest smarter with data-backed trading alerts - Jammu Links News
Is it the right time to buy Atara Biotherapeutics Inc. stockConsistent high-yield stocks - Jammu Links News
What makes Atara Biotherapeutics Inc. stock price move sharplyNavigate market shifts with confidence - Jammu Links News
FDA Accepts Atara Biotherapeutics’ Resubmission of BLA for Tabelecleucel - CGTLive®
Atara Biotherapeutics Plunges 16.09% Post Reverse Split - AInvest
Atara Biotherapeutics Inc. Stock Lags Behind Sector BenchmarksHigh Accuracy Alerts for ROI Traders Detected - metal.it
Atara Biotherapeutics Inc. Recovery Potential Based on Technical ToolsValue Investing Picks With Stability Outlined - metal.it
Published on: 2025-07-29 09:26:28 - metal.it
Fibonacci Support Holding Strong in Atara Biotherapeutics Inc.Multi-Bagger Potential Stock Forecast Tools Released - metal.it
Published on: 2025-07-28 23:04:32 - metal.it
Is Atara Biotherapeutics Inc. a growth stock or a value stockRapid return acceleration - Jammu Links News
Intrinsic Value of Atara Biotherapeutics Inc. Stock: Is It Undervalued or Overvalued Portfolio Positioning Strategy With Timing - metal.it
What are the technical indicators suggesting about Atara Biotherapeutics Inc.Build wealth faster with disciplined trading - Jammu Links News
Atara Biotherapeutics Inc (ATRA) 財務データ
収益
当期純利益
現金流量
EPS
Atara Biotherapeutics Inc (ATRA) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Grant-Huerta Yanina | Chief Accounting Officer |
May 16 '25 |
Sale |
6.76 |
2,218 |
15,000 |
37,067 |
| Nguyen AnhCo | President and CEO |
May 16 '25 |
Sale |
6.76 |
3,276 |
22,156 |
70,847 |
0.91%
3.06%
大文字化:
|
ボリューム (24 時間):